Send feedback

CFAP161 p.Pro110Leu

c.329C>T · rs201116091 · VCV2225575

Uncertain significance Single submitter
Classification
Uncertain significance
ClinVar
Review
Single submitter ★☆☆☆
ClinVar · 1 submitter
AlphaMissense
likely benign
0.235 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00661%, nfe)
Missense predictors
1/2 damaging
AlphaMissense, SaProt · REVEL no call

Computational evidence

Protein change
AlphaMissense0.235likely benign
REVEL0.367indeterminate
SaProtLLR -12.35damaging
⇒ SaProt calls this damaging; AlphaMissense does not; REVEL makes no call.
Splicing
SpliceAI<0.2all four deltas below 0.2 · C>G here scores Δ0.71 · evaluated, not missing
Constraint at this position
ConservationphyloP 7.5phastCons 1
Regional constrainto/e 0.99unconstrained · MANE · 14 kb · p 0.8 · regional, not allelic
Overall
CADD24.8PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00661% European (non-Finnish) · 78/1,180,038 alleles
Filtering AF 0.00538% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00498%
Overall 0.00558% 90/1,613,988 alleles · very rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.0203% 4,934
European (non-Finnish)grpmax 0.00661% 15,129
Remaining individualsnot grpmax-eligible 0.0064% 15,622
African / African-American 0.00134% 74,888
South Asian 0.0011% 91,074

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CFAP161
Protein
p.Pro110Leu
Coding
c.329C>T
MANE Select
NM_173528
dbSNP
rs201116091
Type
single nucleotide variant
Location
chr15:81136685 (GRCh38)
Gene constraint
LOEUF 1.029 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 87.29 · 2 PDB
Full CFAP161 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cfap161-p-pro110leu (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown